Background: Superlatives are exaggerative terms that may not accurately portray a treatment's effectiveness, safety, or availability.
Objectives: The objective of this study was to evaluate the use of superlatives in news articles describing multiple sclerosis treatments.
Methods: We searched Google News for 11 prespecified superlative terms describing multiple sclerosis therapies in online news articles.
Results: We found that news articles commonly describe non-FDA approved multiple sclerosis therapies with superlative terms without providing clinical evidence or attribution. Additionally, no articles were published on a HONcode certified webpage.
Conclusion: It is important that healthcare professionals are aware of medical misinformation presented to the public.
|Journal||Multiple Sclerosis and Related Disorders|
|State||Published - Apr 2021|